Division of Urology, Albany Medical College, Albany, New York.
Social and Scientific Systems, Durham, North Carolina.
J Urol. 2020 Jan;203(1):171-178. doi: 10.1097/JU.0000000000000499. Epub 2019 Aug 20.
Our current understanding of recent trends in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia is incomplete, particularly in younger men. The 2018 Urologic Diseases in America Project attempted to fill this gap by analyzing multiple large administrative claims databases which include men of all ages and permit longitudinal followup. To our knowledge we report these findings for the first time in the scientific literature.
The 2 data sources used in this study included the de-identified Optum® Clinformatics® Data Mart database for men 40 to 64 years old and the Medicare 5% Sample for men 65 years old or older. To assess trends in lower urinary tract symptoms/benign prostatic hyperplasia related medication prescriptions and surgical procedures from 2004 to 2013 we created annual cross-sectional cohorts and a longitudinal cohort of patients with incident lower urinary tract symptoms/benign prostatic hyperplasia and 5 years of followup.
The use of medications related to lower urinary tract symptoms/benign prostatic hyperplasia increased with age, particularly among men 40 to 60 years old. While medication use increased with time, surgical procedures decreased. Increasing age correlated with a higher rate of surgical procedures in the longitudinal cohort. Younger men were more likely to elect treatments of lower urinary tract symptoms/benign prostatic hyperplasia which reportedly optimize sexual function.
Medication use increased and surgery decreased during the study period. Treatment approaches to lower urinary tract symptoms/benign prostatic hyperplasia varied greatly by patient age. While the minority of men in the fifth and sixth decades of life required treatment, a sharp increase in treatment use was seen between these decades. Younger men were more likely to elect less invasive surgical options. Future studies of lower urinary tract symptoms/benign prostatic hyperplasia should focus on age specific treatment selection.
我们目前对与良性前列腺增生相关的下尿路症状管理的最新趋势的了解并不完整,尤其是在年轻男性中。2018 年美国泌尿科疾病项目试图通过分析包括所有年龄段男性并允许进行纵向随访的多个大型行政索赔数据库来填补这一空白。据我们所知,我们首次在科学文献中报告了这些发现。
本研究使用的 2 个数据源包括去识别的 Optum®Clinformatics®Data Mart 数据库,用于 40 至 64 岁的男性,以及 Medicare 5%抽样数据库,用于 65 岁或以上的男性。为了评估 2004 年至 2013 年下尿路症状/良性前列腺增生相关药物处方和手术程序的趋势,我们创建了年度横截面队列和一个有 5 年随访的下尿路症状/良性前列腺增生的纵向队列。
与下尿路症状/良性前列腺增生相关的药物使用随着年龄的增长而增加,尤其是在 40 至 60 岁的男性中。虽然药物使用随时间增加,但手术数量减少。在纵向队列中,年龄的增加与手术率的升高相关。年轻男性更倾向于选择据称能优化性功能的下尿路症状/良性前列腺增生的治疗方法。
在研究期间,药物使用增加,手术减少。下尿路症状/良性前列腺增生的治疗方法因患者年龄而异。虽然在第五和第六个十年的男性中只有少数需要治疗,但在这两个十年之间,治疗的使用明显增加。年轻男性更倾向于选择侵入性较小的手术选择。未来下尿路症状/良性前列腺增生的研究应侧重于特定年龄的治疗选择。